基本信息
浏览量:8
职业迁徙
个人简介
His primary clinical interests are in urologic cancers, and his primary research interests are in cancer immunology and the biology of urologic cancers. Prof Davis is a member of the Medical & Scientific Committee and of the Standing Subcommittee on Research for the Cancer Council Victoria. He founded the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), is a member of COSA Council, and previously a COSA Board director. Prof Davis is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. Prof Davis has published over 250 papers with over 15,000 citations, attracted over $30M in grant funding, and been involved in over 200 clinical trials for which he was global or site Principal Investigator in over 120.
研究兴趣
论文共 488 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
European Urology Oncology (2024)
Cell reports. Medicineno. 2 (2024): 101393-101393
BJU INTERNATIONAL (2024): 39-47
Edmund Chiong,Declan G Murphy,Nicholas Buchan,Kenneth Chen, Sarah S Chen,Melvin L K Chua,Agus Rizal Hamid,Ravindran Kanesvaran,Makarand Khochikar,Jason Letran,Bannakij Lojanapiwat, Indranil Mallik,
European urology (2024)
The Lancet. Oncologyno. 1 (2023): 46-61
The Lancet. Oncologyno. 1 (2023): 99-107
Journal of Clinical Oncologyno. 6_suppl (2023): 600-600
加载更多
作者统计
#Papers: 489
#Citation: 16249
H-Index: 59
G-Index: 120
Sociability: 8
Diversity: 4
Activity: 100
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn